Zimmer set for Smith & Nephew move?
This article was originally published in Clinica
Executive Summary
Media reports this week have suggested that UK medtech firm Smith & Nephew is being targeted by orthopaedics giant Zimmer for a potential takeover. Rumours were rife after S&N's share price went up by 3% in seven trading days on the New York Stock Exchange. The London-based company saw its stock reach $59.34 per share at the close of trading on August 27, up from $57.59 on August 18, suggesting that a bid may be imminent.